YTHDF1 and breast carcinoma: The findings showed that YTHDF1 expression was positively linked with the majority of the immunological checkpoints relevant to breast cancer, indicating that YTHDF1 is probably a target for treating breast cancer and determining the effectiveness of therapeutic interventions [48].